{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:55:49Z","timestamp":1789757749143,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:00:00Z","timestamp":1588982400000},"content-version":"am","delay-in-days":313,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.drugalcdep.2019.03.011","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T08:30:56Z","timestamp":1557304256000},"page":"26-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4664-009X","authenticated-orcid":false,"given":"Rebecca L.","family":"Ashare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7107-2947","authenticated-orcid":false,"given":"Morgan","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9688-2287","authenticated-orcid":false,"given":"David","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Hole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karam","family":"Mounzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald G.","family":"Collman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Paul","family":"Wileyto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schnoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0005","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s10461-016-1343-8","article-title":"Long-term cigarette smoking trajectories among HIV-seropositive and seronegative MSM in the multicenter AIDS cohort study","volume":"20","author":"Akhtar-Khaleel","year":"2016","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0010","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/infdis\/jiw434","article-title":"The shifting paradigm of care for adults living with HIV: smoking cessation for longer life","volume":"214","author":"Althoff","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0015","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/14622200210123581","article-title":"Biochemical verification of tobacco use and cessation","volume":"4","author":"Benowitz","year":"2002","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1037\/0893-164X.12.2.101","article-title":"Reliability and validity of a smoking timeline follow-back interview","volume":"12","author":"Brown","year":"1998","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0030","first-page":"CD006103","article-title":"Nicotine receptor partial agonists for smoking cessation","author":"Cahill","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ntr\/ntr003","article-title":"Adherence to varenicline in the COMPASS smoking cessation intervention trial","volume":"13","author":"Catz","year":"2011","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0040","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1080\/09540121.2018.1489103","article-title":"Perceived barriers to smoking cessation and perceptions of electronic cigarettes among persons living with HIV","volume":"30","author":"Cioe","year":"2018","journal-title":"AIDS Care"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0045","article-title":"Predictors of varenicline adherence among cancer patients treated for tobacco dependence and its association with smoking cessation","author":"Crawford","year":"2018","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/apc.2011.0199","article-title":"Safety and tolerability of varenicline tartrate (Champix\u00ae\/Chantix\u00ae) for smoking cessation in HIV-infected subjects: a pilot open-label study","volume":"26","author":"Cui","year":"2012","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/ntr\/nts121","article-title":"Safety of varenicline among smokers enrolled in the lung HIV study","volume":"15","author":"Ferketich","year":"2013","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0060","first-page":"1217","article-title":"Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary","volume":"53","author":"Fiore","year":"2008","journal-title":"Respir. Care"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial","volume":"296","author":"Gonzales","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0070","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/clpt.2014.124","article-title":"Retreatment with varenicline for smoking cessation in smokers who have previously taken varenicline: a randomized, placebo-controlled trial","volume":"96","author":"Gonzales","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0075","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/ciu862","article-title":"Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study","volume":"60","author":"Heaton","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0080","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/cid\/cis933","article-title":"Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study","volume":"56","author":"Helleberg","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0085","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/add.12009","article-title":"Past major depression and smoking cessation outcome: a systematic review and meta-analysis update","volume":"108","author":"Hitsman","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/QAI.0b013e31815724fe","article-title":"HIV\/AIDS-specific quality of life and adherence to antiretroviral therapy over time","volume":"46","author":"Holmes","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/1462220031000070552","article-title":"Measures of abstinence in clinical trials: issues and recommendations","volume":"5","author":"Hughes","year":"2003","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0376-8716(94)90158-9","article-title":"Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI","volume":"34","author":"Kozlowski","year":"1994","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0105","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/ntr\/ntw126","article-title":"Smoking cessation for people living with HIV\/AIDS: a literature review and synthesis","volume":"18","author":"Ledgerwood","year":"2016","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S2213-2600(14)70294-2","article-title":"Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial","volume":"3","author":"Lerman","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0115","doi-asserted-by":"crossref","first-page":"e1002020","DOI":"10.1371\/journal.pmed.1002020","article-title":"Smoking behavior and healthcare expenditure in the United States, 1992\u20132009: panel data estimates","volume":"13","author":"Lightwood","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0120","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/npp.2014.318","article-title":"Working memory-related neural activity predicts future smoking relapse","volume":"40","author":"Loughead","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0125","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1016\/S2214-109X(17)30170-5","article-title":"Tobacco use among people living with HIV: analysis of data from demographic and health surveys from 28 low-income and middle-income countries","volume":"5","author":"Mdege","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M14-0954","article-title":"Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys","volume":"162","author":"Mdodo","year":"2015","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0135","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1016\/S2352-3018(18)30002-X","article-title":"Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 inter-ACTIV): a randomised controlled phase 3 clinical trial","volume":"5","author":"Mercie","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0140","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s11920-014-0530-4","article-title":"Depression in HIV infected patients: a review","volume":"17","author":"Nanni","year":"2015","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0145","series-title":"Early Release of Selected Estimates Based on Data from the National Health Interview Survey","author":"Norris","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0150","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11904-015-0281-9","article-title":"Tobacco use, use disorders, and smoking cessation interventions in persons living with HIV","volume":"12","author":"Pacek","year":"2015","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0155","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1080\/09540121.2017.1330532","article-title":"Positive smoking cessation-related interactions with HIV care providers increase the likelihood of interest in cessation among HIV-positive cigarette smokers","volume":"29","author":"Pacek","year":"2017","journal-title":"AIDS Care"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0160","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/ntr\/ntx210","article-title":"Adherence to pharmacological smoking cessation interventions: a literature review and synthesis of correlates and barriers","volume":"20","author":"Pacek","year":"2018","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0165","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.addbeh.2017.07.006","article-title":"Measures and predictors of varenicline adherence in the treatment of nicotine dependence","volume":"75","author":"Peng","year":"2017","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0170","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/COH.0000000000000306","article-title":"Smoking, alcohol and illicit drug use effects on survival in HIV-positive persons","volume":"11","author":"Petoumenos","year":"2016","journal-title":"Curr. Opin. HIV AIDS."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0175","first-page":"CD011120","article-title":"Interventions for tobacco use cessation in people living with HIV and AIDS","author":"Pool","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0180","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am. J. Psychiatry."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0185","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/pon.4166","article-title":"The use of varenicline to treat nicotine dependence among patients with cancer","volume":"26","author":"Price","year":"2017","journal-title":"Psychooncology"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0190","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/COH.0000000000000407","article-title":"Tobacco, illicit drugs use and risk of cardiovascular disease in patients living with HIV","volume":"12","author":"Raposeiras-Roubin","year":"2017","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0195","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/infdis\/jiw430","article-title":"Impact of cigarette smoking and smoking cessation on life expectancy among people with HIV: a US-based modeling study","volume":"214","author":"Reddy","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0200","doi-asserted-by":"crossref","first-page":"144","DOI":"10.7326\/0003-4819-152-3-201002020-00005","article-title":"Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial","volume":"152","author":"Schnoll","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0205","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/jamainternmed.2014.8313","article-title":"Long-term nicotine replacement therapy: a randomized clinical trial","volume":"175","author":"Schnoll","year":"2015","journal-title":"JAMA Intern. Med."},{"issue":"2","key":"10.1016\/j.drugalcdep.2019.03.011_bib0210","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1097\/QAI.0000000000001895","article-title":"Rate of nicotine metabolism and tobacco use among persons with HIV: implications for treatment and research","volume":"80","author":"Schnoll","year":"2019","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.drugalcdep.2019.03.011_bib0215","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/pon.4978","article-title":"A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: efficacy, safety, and adherence","volume":"28","author":"Schnoll","year":"2019","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0220","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.drugalcdep.2017.03.021","article-title":"Trends in utilization of smoking cessation agents before and after the passage of FDA boxed warning in the United States","volume":"177","author":"Shah","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"Suppl. 20","key":"10.1016\/j.drugalcdep.2019.03.011_bib0225","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric Interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0230","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/ntr\/ntv068","article-title":"Correlates of adherence to varenicline among HIV+ smokers","volume":"17","author":"Shelley","year":"2015","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0235","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002849","article-title":"Varenicline and adverse cardiovascular events: a systematic review and meta-analysis of randomized controlled trials","volume":"5","author":"Sterling","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0240","doi-asserted-by":"crossref","DOI":"10.3390\/jpm7040018","article-title":"Variation in CYP2A6 activity and personalized medicine","volume":"7","author":"Tanner","year":"2017","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0245","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.296.1.64","article-title":"Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial","volume":"296","author":"Tonstad","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0250","doi-asserted-by":"crossref","first-page":"S555","DOI":"10.1080\/14622200701673480","article-title":"Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence","volume":"9","author":"Transdisciplinary Tobacco Use Research Center Tobacco Dependence","year":"2007","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0255","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1007\/s10461-016-1538-z","article-title":"Combining text messaging and telephone counseling to increase varenicline adherence and smoking abstinence among cigarette smokers living with HIV: a randomized controlled study","volume":"21","author":"Tseng","year":"2016","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0260","unstructured":"U.S. Department of Health and Human Services AIDS.gov: HIV and smoking. U.S. Department of Health and Human Services, Washington, D.C."},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0265","doi-asserted-by":"crossref","first-page":"e97698","DOI":"10.1371\/journal.pone.0097698","article-title":"Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study","volume":"9","author":"Valiathan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0270","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/COH.0000000000000298","article-title":"Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population","volume":"11","author":"Wandeler","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0275","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/09540121.2017.1382678","article-title":"Perceived risks and benefits of quitting smoking in a sample of adults living with HIV\/AIDS","volume":"30","author":"Weinberger","year":"2018","journal-title":"AIDS Care"},{"key":"10.1016\/j.drugalcdep.2019.03.011_bib0280","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/add.13415","article-title":"Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis","volume":"111","author":"Wu","year":"2016","journal-title":"Addiction"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619301401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619301401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:56:35Z","timestamp":1759827395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619301401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":56,"alternative-id":["S0376871619301401"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.03.011","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}